{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:57:57Z","timestamp":1767920277960,"version":"3.49.0"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    : Little is known about the nutritional status of patients with peritoneal metastasis (PM), in particular about the evolution of the so-called anorexia-cachexia syndrome in these patients. The objective of the study was to assess nutritional status in PM patients at the end of life, including metabolic aspects.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    : Observational study. Prospective nutritional status assessment in 87 PM patients, including Subjective Global Assessment: (SGA), physical examination (body mass index [BMI], bioelectrical impedance analysis [BIA], anthropometry and blood chemistry).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : 85\u2006% patients had received previous chemotherapy. Peritoneal carcinomatosis index was 16\u00b111, Karnofsky 81\u00b114\u2006% and ascites volume 1,000\u00b11,690\u2006ml. SGA was reduced with 22.0\u00b19.6 points, BMI normal with 25.3\u00b15.8\u2006kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    and resting metabolism was 1,527\u00b1248\u2006kcal\/day. Serum total protein and albumin were at the inferior normal limit (6.5\u00b10.8\u2006g\/dl, respectively 3.7\u00b10.8\u2006g\/dl) and C-reactive protein (CRP) was elevated (2.9\u00b14.1\u2006g\/dl). Serum levels of protein (p=0.05), albumin (p=0.003) and transferrin (p=0.001) were higher in gastrointestinal than in ovarian PM patients. When patients were grouped according to time from first assessment to death, serum protein and albumin decreased until end of life, whereas ascites volume, resting metabolism and CRP increased.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Both increased resting metabolism and decreased caloric intake contribute to the development of the cachexia-anorexia syndrome in PM patients. End of life is caused by energetic dysbalance and exhaustion.\n                  <\/jats:p>","DOI":"10.1515\/pp-2016-0003","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T15:15:08Z","timestamp":1460560508000},"page":"57-63","source":"Crossref","is-referenced-by-count":16,"title":["Cachexia-anorexia syndrome in patients with peritoneal metastasis: an observational study"],"prefix":"10.1515","volume":"1","author":[{"given":"Katharina","family":"Nordhausen","sequence":"first","affiliation":[{"name":"University of Magdeburg, Department of Surgery, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Solass","sequence":"additional","affiliation":[{"name":"Medical School Hanover, Institute of Pathology, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"Demtroeder","sequence":"additional","affiliation":[{"name":"Departmnet of Surgical Oncology, Ruhr-University Bochum, Marien Hospital Herne, Herne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens B.","family":"Tempfer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Ruhr-University Bochum, Marien Hospital Herne, Herne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Reymond","sequence":"additional","affiliation":[{"name":"Departmnet of Surgical Oncology, Ruhr-University Bochum, Marien Hospital Herne, Herne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"2025120909190351610_j_pp-2016-0003_ref_001_w2aab3b7c15b1b6b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"1. Evans WJ, Morley JE, Argil\u00e9s J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793\u20139.","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"2025120909190351610_j_pp-2016-0003_ref_002_w2aab3b7c15b1b6b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"2. Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F. Therapy insight: Cancer anorexia-cachexia syndrome\u2013when all you can eat is yourself. Nat Clin Pract Oncol 2005;2:158\u201365.","DOI":"10.1038\/ncponc0112"},{"key":"2025120909190351610_j_pp-2016-0003_ref_003_w2aab3b7c15b1b6b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Donohoe CL, Ryan AM, Reynolds JV. Cancer cachexia: Mechanisms and clinical implications. Gastroenterol Res Pract 2011;2011:601434.","DOI":"10.1155\/2011\/601434"},{"key":"2025120909190351610_j_pp-2016-0003_ref_004_w2aab3b7c15b1b6b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"4. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358\u201363.","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"key":"2025120909190351610_j_pp-2016-0003_ref_005_w2aab3b7c15b1b6b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Romero I, Bast RC Jr. Minireview: Human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology 2012;153:1593\u2013602.","DOI":"10.1210\/en.2011-2123"},{"key":"2025120909190351610_j_pp-2016-0003_ref_006_w2aab3b7c15b1b6b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"6. Thomassen I, Verhoeven RH, van Gestel YR, van de Wouw AJ, Lemmens VE, de Hingh IH. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin. Eur J Cancer 2014;50:50\u20136.","DOI":"10.1016\/j.ejca.2013.08.009"},{"key":"2025120909190351610_j_pp-2016-0003_ref_007_w2aab3b7c15b1b6b1ab2ab7Aa","unstructured":"7. www.subjectiveglobalassessment.com, Jeejeebhoy Holdings Inc. Accessed 29 May 2014."},{"key":"2025120909190351610_j_pp-2016-0003_ref_008_w2aab3b7c15b1b6b1ab2ab8Aa","unstructured":"8. http:\/\/www.omron-healthcare.de\/unsere-produkte\/gewichtskontrolle\/bf511. Accessed 08 Jun 2014."},{"key":"2025120909190351610_j_pp-2016-0003_ref_009_w2aab3b7c15b1b6b1ab2ab9Aa","unstructured":"9. http:\/\/www.eaglefit.de\/berechnung.xls. Accessed 29 May 2014."},{"key":"2025120909190351610_j_pp-2016-0003_ref_010_w2aab3b7c15b1b6b1ab2ac10Aa","unstructured":"10. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89:381-410. Review."},{"key":"2025120909190351610_j_pp-2016-0003_ref_011_w2aab3b7c15b1b6b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"11. Odendahl K, Solass W, Demtr\u00f6der C, Giger-Pabst U, Zieren J, Tempfer C et al. Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Eur J Surg Oncol 2015;41:1379\u201385.","DOI":"10.1016\/j.ejso.2015.06.001"},{"key":"2025120909190351610_j_pp-2016-0003_ref_012_w2aab3b7c15b1b6b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"12. Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care: correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 2005;103:2189\u201398.","DOI":"10.1002\/cncr.21013"},{"key":"2025120909190351610_j_pp-2016-0003_ref_013_w2aab3b7c15b1b6b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;5930:1029\u20131033.","DOI":"10.1126\/science.1160809"},{"key":"2025120909190351610_j_pp-2016-0003_ref_014_w2aab3b7c15b1b6b1ab2ac14Aa","unstructured":"14. Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia\u2013pathophysiology and management. J Gastroenterol 2013;48:574-94. Review."},{"key":"2025120909190351610_j_pp-2016-0003_ref_015_w2aab3b7c15b1b6b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Klein C, Stiel S, B\u00fckki J, Ostgathe C. Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients: a systematic literature review. Schmerz 2012;26:587\u201399.","DOI":"10.1007\/s00482-012-1247-0"},{"key":"2025120909190351610_j_pp-2016-0003_ref_016_w2aab3b7c15b1b6b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"16. O\u2019Connor B, Creedon B. Pharmacological treatment of bowel obstruction in cancer patients. Expert Opin Pharmacother 2011;12:2205\u201314.","DOI":"10.1517\/14656566.2011.597382"},{"key":"2025120909190351610_j_pp-2016-0003_ref_017_w2aab3b7c15b1b6b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"17. Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr 2008;27:5\u201315.","DOI":"10.1016\/j.clnu.2007.10.007"},{"key":"2025120909190351610_j_pp-2016-0003_ref_018_w2aab3b7c15b1b6b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"18. Cherwin CH. Gastrointestinal symptom representation in cancer symptom clusters: a synthesis of the literature. Oncol Nurs Forum 2012;39:157\u201365.","DOI":"10.1188\/12.ONF.157-165"},{"key":"2025120909190351610_j_pp-2016-0003_ref_019_w2aab3b7c15b1b6b1ab2ac19Aa","doi-asserted-by":"crossref","unstructured":"19. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland Jr KM, et al. A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer 2007;110:1396e403.","DOI":"10.1002\/cncr.22944"},{"key":"2025120909190351610_j_pp-2016-0003_ref_020_w2aab3b7c15b1b6b1ab2ac20Aa","doi-asserted-by":"crossref","unstructured":"20. Chan CH, Cusack JC, Ryan DP. A critical look at local-regional management of peritoneal metastasis. Hematol Oncol Clin North Am 2015;29:153\u20138.","DOI":"10.1016\/j.hoc.2014.09.006"},{"key":"2025120909190351610_j_pp-2016-0003_ref_021_w2aab3b7c15b1b6b1ab2ac21Aa","unstructured":"21. Katharina N, Wiebke S, Cedric D, Clemens B. Tempfer and Marc A. Reymond. Intraperitoneal cancer therapy: Principles and practice. CRC press (Taylor and Francis), Boca Raton, FL, 2016."},{"key":"2025120909190351610_j_pp-2016-0003_ref_022_w2aab3b7c15b1b6b1ab2ac22Aa","doi-asserted-by":"crossref","unstructured":"22. Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, et al. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study. Gynecol Oncol 2015;137:223\u20138.","DOI":"10.1016\/j.ygyno.2015.02.009"},{"key":"2025120909190351610_j_pp-2016-0003_ref_023_w2aab3b7c15b1b6b1ab2ac23Aa","doi-asserted-by":"crossref","unstructured":"23. Fearon K, Argiles JM, Baracos VE, Bernabei R, Coats A, Crawford J, et al. Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle 2015;6:272\u20134.","DOI":"10.1002\/jcsm.12083"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/1\/1\/article-p57.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0003\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T09:38:12Z","timestamp":1765273092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0003\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,12]]},"published-print":{"date-parts":[[2016,3,1]]}},"alternative-id":["10.1515\/pp-2016-0003"],"URL":"https:\/\/doi.org\/10.1515\/pp-2016-0003","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}